Total (N = 102), N (%) | Fellow (N = 55), N (%) | Nonfellow (N = 47), N (%) | p valuea | |
---|---|---|---|---|
Gender | 0.914 | |||
Female | 82 (80.4) | 44 (80.0) | 38 (80.9) | |
Male | 20 (19.6) | 11 (20.0) | 9 (19.1) | |
Cancer area focus | 0.457 | |||
Detection | 16 (15.7) | 11 (20.0) | 5 (10.6) | |
Prevention | 49 (48.0) | 24 (43.6) | 25 (53.2) | |
Survivorship | 18 (17.6) | 11 (20.0) | 7 (14.9) | |
Treatment | 19 (18.6) | 9 (16.4) | 10 (21.3) | |
Position | 0.475 | |||
Associate professor or professor | 15 (14.7) | 10 (18.2) | 5 (10.6) | |
Assistant professor | 47 (46.1) | 27 (49.1) | 20 (42.6) | |
Post-doctoral or research fellow | 22 (21.6) | 10 (18.2) | 12 (25.5) | |
Others | 18 (17.6) | 8 (14.5) | 10 (21.3) | |
Home institution within the USA | 0.242 | |||
No | 15 (14.7) | 6 (10.9) | 9 (19.1) | |
Yes | 87 (85.3) | 49 (89.1) | 38 (80.9) | |
Years from an undergraduate degree at the time of application, mean (SD) | 17.9 (6.7) | 18.2 (6.3) | 17.4 (7.2) | 0.565 |
Application year (cohort) | 0.011 | |||
2014 | 21 (20.6) | 13 (23.6) | 8 (17.0) | |
2015 | 22 (21.6) | 15 (27.3) | 7 (14.9) | |
2016 | 18 (17.6) | 13 (23.6) | 5 (10.6) | |
2017 | 41 (40.2) | 14 (25.5) | 27 (57.4) |